β -Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells
Chemotherapy Research and Practice · 2012
DOI: 10.1155/2012/192362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemotherapy Research and Practice, 2012. Verfasst von Mireia Nager und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Basic Medical Sciences and Experimental Medicine, IRBLleida University of Lleida, 25198 Lleida, Spain. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is a commonly occurring brain tumor with a poor prognosis. GBM can develop both “de novo” or evolve from a previous astrocytoma and is characterized by high proliferation and infiltration into the surrounding tissue. Following treatment (surgery, radiotherapy, and chemotherapy), tumors often reappear. Glioma-initiating cells (GICs) have been identified in GBM and are thought to be responsible for tumors initiation, their continued growth, and recurrence. β -catenin, a component of the cell-cell adhesion complex and of the canonical Wnt pathway, regulates proliferation, adhesion, and migration in different cell types. β -catenin and components of the Wnt canonical pathway are commonly overexpressed in GBM. Here, we review previous work on the role of Wnt/ β -catenin signalling in glioma initiation, proliferation, and invasion. Understanding the molecular mechanisms regulating GIC biology and glioma progression may help in identifying novel therapeutic targets for GBM treatment.
Autor:innen und Institutionen
- Departments of Basic Medical Sciences and Experimental Medicine, IRBLleida University of Lleida, 25198 Lleida, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Nager, M., Bhardwaj, D., Cantí, C., Medina, L., Nogués, P., & Herreros, J. (2012). β -Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells. Chemotherapy Research and Practice. https://doi.org/10.1155/2012/192362
Vancouver
Nager M, Bhardwaj D, Cantí C, Medina L, Nogués P, Herreros J. β -Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells. Chemotherapy Research and Practice. 2012. doi:10.1155/2012/192362
BibTeX
@article{Nager2012,
author = {Nager, Mireia and Bhardwaj, Deepshikha and Cantí, Carles and Medina, Loreta and Nogués, Pere and Herreros, Judit},
title = {β -Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells},
journal = {Chemotherapy Research and Practice},
year = {2012},
doi = {10.1155/2012/192362}
}
EUVIMED